Search Results - "Ruddock, M. W."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Nicotinamide-inhibited vasoconstriction: lack of dependence on agonist signalling pathways by Burns, Deirdre M, Ruddock, Mark W, Walker, Mark D, Allen, James M, Kennovin, Gordon D, Hirst, David G

    Published in European journal of pharmacology (18-06-1999)
    “…Previously, we have shown that nicotinamide inhibits both high [K +]- and phenylephrine-induced constrictions in a dose-dependent manner in rat tail arteries…”
    Get full text
    Journal Article
  2. 2

    The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle by Ruddock, Mark W, Burns, Deirdre M, Murphy, Lynne E, O'Rourke, Martin G, Hirst, David G

    Published in Radiotherapy and oncology (01-08-2000)
    “…Background and purpose: Nicotinamide (NA) is currently undergoing clinical trials as a tumour radiosensitizer. The dose that can be administered is currently…”
    Get full text
    Journal Article
  3. 3

    Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide by Ruddock, Mark W, Burns, Deirdre M, McKeown, Stephanie R, Murphy, Lynn, Walsh, Ian K, Keane, Patrick F, Hirst, David G

    Published in Radiotherapy and oncology (01-02-2000)
    “…Background and purpose: The manipulation of tumour blood supply and thus oxygenation is a potentially important strategy for improving the treatment of solid…”
    Get full text
    Journal Article
  4. 4

    Saturated Fatty Acids Inhibit Hepatic Insulin Action by Modulating Insulin Receptor Expression and Post-receptor Signalling by Ruddock, Mark W, Stein, Andrew, Landaker, Edwin, Park, Jun, Cooksey, Robert C, McClain, Donald, Patti, Mary-Elizabeth

    Published in Journal of biochemistry (Tokyo) (01-11-2008)
    “…Free fatty acids (FFAs) are proposed to play a pathogenic role in both peripheral and hepatic insulin resistance. We have examined the effect of saturated FFA…”
    Get full text
    Journal Article
  5. 5

    Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review by McNally, Christopher J, Ruddock, Mark W, Moore, Tara, McKenna, Declan J

    Published in Cancer management and research (01-07-2020)
    “…Prediction of prostate cancer in primary care is typically based upon serum total prostate-specific antigen (tPSA) and digital rectal examination results…”
    Get full text
    Journal Article
  6. 6

    Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival by Watt, Joanne, Maguire, Daniel G, Reid, Cherith N, Lamont, John V, Fitzgerald, Stephen P, Ruddock, Mark W

    Published in Research and reports in urology (01-01-2020)
    “…Decreased expression of thrombomodulin (TM) in bladder cancer tissue has been shown to be associated with cell proliferation, increased malignancy and a poor…”
    Get full text
    Journal Article
  7. 7

    Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy by Ruddock, Mark W, Hirst, David G

    Published in Oncology research (2004)
    “…Nicotinamide has been shown to be an effective tumor oxygenator in preclinical studies and is part of a promising clinical protocol for the treatment of cancer…”
    Get more information
    Journal Article
  8. 8

    Pentoxifylline inhibits agonist-induced vasoconstriction in vascular smooth muscle and spontaneous peristalsis in isolated ileum by Ruddock, Mark W, Hirst, David G

    Published in Oncology research (01-01-2005)
    “…Pentoxifylline (PTX) is currently used therapeutically as a tumor oxygenator where it been shown to increase tumor blood flow and potentiate ionizing radiation…”
    Get more information
    Journal Article
  9. 9
  10. 10